Pure Global

Anti Cardiolipin IgG - India CDSCO Medical Device Registration

Anti Cardiolipin IgG is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2018/000022_4e8ecaf0f5e20f8dc11e743e3006faec_406999344fbc7d03049aa6055ca287b0. This device is marketed under the brand name Merilisa. The license holder is Meril Diagnostics Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is Gujarat.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Anti Cardiolipin IgG
UID: MFG/MD/2018/000022_4e8ecaf0f5e20f8dc11e743e3006faec_406999344fbc7d03049aa6055ca287b0

Brand Name

Merilisa

Device Class

Class B

Approving Authority

Gujarat

Product Information

Anti Cardiolipin IgG kit is an indirect solid phase immunoassay kit for the quantitative measurement of IgG class auto-antibodies directed against Cardiolipina-ฮฒ2- glycoprotein complex in human serum or plasma. The assay is intended for in vitro diagnostic use only as an aid in the diagnosis of increased risk of thrombosis in patients with Systemic Lupus Eritematosus (Merilisa) or similar disorders. Anti Cardiolipin IgG kit is intended for laboratory use only

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing